Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-316-5 | CAS number: 1155405-88-1
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Absorption is not predicted for the intact substance, however limted gastrointestianl hydrolysis in the rat may occur and hydroylsis prodcuts are likely to be absorbed.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The water solubility of the registered substance is very low, therefore dissolution is regarded to be the rate limiting step for gastrointestinal absorption. Data from the rat and dog indicate that the intact substance is not likely to be absorbed, but will be hydrolysed by gastro-intestinal esterases. Hydrolysis in the rat is readily saturated and is insignificant at high levels of exposure, whereas a higher level of hydrolysis (~50%) is seen in the dog at high dose levels. This assessment is based on data from studies with mixed (mono-, di- and tri-) citrate esters of stearic alcohol (C18; stearyl citrate), whereas the registered substance consists of tri-citrate esters of C18, C20 and C22. The limited absorption seen with the test material used in this study is likely to be due largely to the mono-citrate ester, the results therefore indicate that the absorption of the registered substance (which consists of tri-esters only) will be even more limited in the rat
The gastrointestinal absorption of the hydrolysis products (citric acid, C18, C20, C22 fatty alcohols) is predicted; data from the dog indicate the saturation of fatty alcohol absorption at high levels of exposure.
Dermal absorption of the substance is not predicted based on its physicochemical properties. Inhalation exposure to the substance is not predicted based on its physicochemical properties.
Systemic distribution of the intact substance is not predicted. Following gastrointestinal hydrolysis, absorption and subsequent distribution of the hydrolysis product citric acid is predicted. Citric acid is a normal metabolic intermediate; citric acid resulting from hydrolysis of the registered substance and will distributed systemically but will be indistinguishable from the large amounts of citric acid normally present in the body. Data indicate that fatty alcohols are oxidised to the corresponding fatty acid in the enterocytes on absorption from the gastrointestinal tract. Fatty acids will be distributed to the liver and incorporated into normal metabolic pathways.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
